Anticoagulant Drugs
9
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Effect of Oral Antiplatelet or Anticoagulant Drugs on Postoperative Bleeding Risk and Venous Closure Rate in Patients With Lower Extremity Varicose Veins After Radiofrequency Ablation
Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years
Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients
Effect of Injectable Anticoagulants on Research for a Circulating Lupus-type Anticoagulant
Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant Prescriptions
Effect of Anticoagulant Drug Intervention on Postoperative MALE and MACE in Patients With PAD
Discontinuation for Oral Anticoagulants in Patients With Atrial Fibrillation
Effect of an Electronic Reminder System on Direct Oral Anticoagulant and Oral Diabetes Medication Adherence
E-learning to Improve Oral Anticoagulant Use in Hospitalized Older People With AF